General MedicationsORALStandard

TIZANIDINE HYDROCHLORIDE

Standard Dose

EQ 2MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview TIZANIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 213798 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TIZANIDINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 2MG BASE Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2020-05-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview TIZANIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 213798 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TIZANIDINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - EQ 2MG BASE Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2020-05-27 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.